繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

随着季度调整后净利润下降,Aurora Cannabis下跌

2026-02-05 02:19

  • Although Aurora Cannabis' (ACB) fiscal 2026 Q3 revenue was a beat, the company's adjusted net income dropped year-over-year, leading shares down ~9% in Wednesday trading.
  • Adjusted net income in the quarter was ~$7.2M compared to ~$7.4M in the year-ago period.
  • Aurora was hampered by an increase in adjusted SG&A expenses of $35.8M compared to $31.3M in FY25 Q3.
  • The company also said it has made a strategic decision to focus resources on the global medical cannabis market.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。